How Clinicians Prioritize Factors in Red Blood Cell Transfusions While Following Guidelines – AABB
Association for the Advancement of Blood and Biotherapies (AABB) shared a post on LinkedIn about a recent article by Aishwarya Katiki et al. published in Transfusion:
“AABB guidelines recommend a restrictive red blood cell transfusion strategy for most patient populations, while emphasizing the importance of considering individual signs, symptoms and clinical context when making transfusion decisions.
How do clinicians prioritize these factors in practice?
A survey of inpatient providers at UChicago Medicine explored which factors clinicians consider most important when deciding whether to transfuse.
Among 30 potential decision factors, seven were rated ‘very important’ by more than two-thirds of respondents, including five hemoglobin-related factors.”
José Antonio García Erce, Director of the Donation Center at Navarre Health Service (Osasunbidea), shared this post on LinkedIn:
“Are the criteria Restrictive?
No, they are obvious criteria!
It is Scientific and Ethical evidence!”
Title: Provider perceptions of indications for red blood cell transfusion
Authors: Aishwarya Katiki, Selwyn Rogers, Ryan Boudreau, David Meltzer, Micah Prochaska
Read the Full Article on Transfusion
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026